TABLE 3.
Variable | All patients
|
Addis Ababa residents
|
||||||
---|---|---|---|---|---|---|---|---|
Clustered (n = 51) | Nonclustered (n = 70) | Adjusted ORa (95% CI) | P value | Clustered (n = 37) | Nonclustered (n = 54) | Adjusted ORb (95% CI) | P value | |
Mean age (yr [median; range]) | 29.3 (29.0;16-50) | 31.1 (28.0;15-62) | 3.69 (0.61-25.48) | 0.17 | 29.7 (30;17-50) | 31.2 (29;15-65) | 2.43 (0.25-27.51) | 0.45 |
Sex (no. [%] of patients) | ||||||||
Male | 30 (58.8) | 48 (68.6) | 19 (51.4) | 38 (70.4) | 1.00 | 0.11 | ||
Female | 21 (41.2) | 22 (31.4) | 18 (48.7) | 16 (29.6) | 2.10 (0.85-5.25) | |||
No. (%) of patients with: | ||||||||
Residence in Addis Ababa | 40 (78.4) | 51 (72.9) | ||||||
Previous TB treatment | 8 (15.7) | 10 (14.3) | 5 (13.5) | 7 (13.0) | ||||
Isolate resistance with (any drug) | 7 (13.2) | 10 (14.7) | 7 (16.7) | 7 (14.3) | ||||
Positive for AFB by direct exam- ination of a sputum smear | 28 (54.9) | 39 (55.7) | 19 (51.4) | 29 (53.7) | ||||
Cavitary TB | 16 (31.4) | 32 (32.9) | 11 (29.7) | 17 (31.5) | ||||
HIV status (no. [%] of patients) | ||||||||
Positive | 37 (70.6) | 36 (51.4) | 2.55 (1.17-5.80) | 0.021 | 28 (75.7) | 32 (59.3) | 2.33 (0.90-6.45) | 0.088 |
Negative | 15 (29.4) | 34 (48.6) | 1.00 | 9 (24.3) | 22 (40.7) | 1.00 |
The final model includes age and HIV infection status. The remaining variables are not significant in the multivariate model.\
The final model includes age, sex, and HIV infection status. The remaining variables are not significant in the multivariate model.